At the end of Q3 2025, 29 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings, unchanged from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Adage Capital Partners Gp, L.L.C. ($31K), Saba Capital Management, L.P. ($29K) and Linden Advisors LP ($25K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
Company
Aspire Biopharma Holdin-CW27
CUSIP
738920115
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
Institutions
Total Value
New Positions
3
$11K
Exits
2
$19K
All 13F filers, Q2 2025 → Q3 2025: 317,169 shares bought and 321,383 shares sold, net −4,214 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.